CAS: 499796-71-3 - 5-fluoropyridine-2-carboxamide
Formula:C6H5FN2O
InChI:InChI=1S/C6H5FN2O/c7-4-1-2-5(6(8)10)9-3-4/h1-3H,(H2,8,10)
InChI key:InChIKey=CWKOQDDWKWTOCF-UHFFFAOYSA-N
SMILES:O=C(N)C1=NC=C(F)C=C1
- Synonyms:
- 2-Pyridinecarboxamide, 5-fluoro-
- 5-Fluoro-2-pyridinecarboxamide
- 5-Fluoropicolinamide
- 5-Fluoropyridinamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-Pyridinecarboxamide,5-fluoro-(9CI) REF: IN-DA00DHZBCAS: 499796-71-3 | 97% | 24.00 €~638.00 € | Wed 11 Dec 24 | |
5-Fluoro-2-pyridinecarboxamide REF: 54-PC408426CAS: 499796-71-3 | 98+% | 32.00 €~664.00 € | Wed 18 Dec 24 | |
5-Fluoropicolinamide REF: 10-F238381CAS: 499796-71-3 | 95.0% | To inquire | Mon 23 Dec 24 | |
5-Fluoropicolinamide REF: 3D-FF31642CAS: 499796-71-3 | Min. 95% | - - - | Discontinued product |
2-Pyridinecarboxamide,5-fluoro-(9CI)
CAS:499796-71-3
Formula:
C6H5FN2O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
140.1151
Ref: IN-DA00DHZB
1g | 28.00 € | ||
5g | 66.00 € | ||
10g | 103.00 € | ||
25g | 149.00 € | ||
250mg | 24.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
5-Fluoro-2-pyridinecarboxamide
CAS:499796-71-3
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
140.12g/mol
Ref: 54-PC408426
1g | 32.00 € | ||
5g | 49.00 € | ||
25g | 191.00 € | ||
100g | 664.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
5-Fluoropicolinamide
CAS:499796-71-3
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
140.11700439453125
Ref: 10-F238381
1g | 20.00 € | ||
5g | 38.00 € | ||
10g | 75.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
5-Fluoropicolinamide
CAS:499796-71-3
5-Fluoropicolinamide is a carboxylate that has been shown to bind to the opioid receptor in …
Formula:
C6H5FN2O
Purity:
Min. 95%
Molecular weight:
140.12 g/mol
Ref: 3D-FF31642
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
25g | Discontinued | Request information | |
50g | Discontinued | Request information | |
100g | Discontinued | Request information |